We demonstrate that miR-369-3p may ameliorate the inflammatory state of IBD patients by modulating the NLRP3 inflammasome complex, thereby suggesting potential new therapeutic approaches in intestinal inflammation. This evidence concerns the gene NLRP3 and gastroenteritis.